Jerusalem Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.22	11.74	6.59	7.73	5.44
Short-Term Investments	-	-	0.05	0.03	0.03
Trading Asset Securities	-	-	-	0.03	0.03
Cash & Short-Term Investments	12.22	11.74	6.64	7.79	5.49
Cash Growth	4.05%	76.87%	-14.72%	41.69%	171.63%
Accounts Receivable	37.35	28.25	29.95	31.63	30.81
Other Receivables	0.04	-	0	-	-
Receivables	37.39	28.25	29.95	31.63	30.81
Inventory	13.45	8.34	10.41	10.88	14.76
Prepaid Expenses	0.35	0.31	0.51	0.4	0.73
Other Current Assets	2.38	2.89	3.1	2.22	3.33
Total Current Assets	65.79	51.54	50.61	52.91	55.12
Property, Plant & Equipment	28.77	25.9	27.13	25.48	27.47
Long-Term Investments	14.23	7.24	6.42	3.22	0.7
Other Intangible Assets	2.67	1.8	1.55	1.52	3.04
Long-Term Deferred Tax Assets	0.53	0.4	0.28	0.27	0.2
Other Long-Term Assets	2.6	2.27	0.32	0.32	0.37
Total Assets	114.59	89.15	86.32	83.72	86.89
Accounts Payable	7.89	3.69	3.92	6.56	5.11
Accrued Expenses	4	3.58	2.33	1.32	1.99
Short-Term Debt	-	0.46	0.52	0.65	0.78
Current Portion of Long-Term Debt	0.72	0.61	1.13	0.69	0.57
Current Portion of Leases	0.4	0.3	0.48	0.36	0.55
Current Income Taxes Payable	3.67	1.29	2.42	2.67	1.66
Other Current Liabilities	2.61	2.07	1.5	1.46	2.3
Total Current Liabilities	19.3	12	12.32	13.7	12.97
Long-Term Leases	0.21	0.14	0.33	0.49	0.72
Long-Term Unearned Revenue	0.52	0.29	-	-	-
Pension & Post-Retirement Benefits	6.36	5.12	4.79	4.3	4.64
Total Liabilities	26.39	17.55	17.44	18.49	18.32
Common Stock	18	18	18	18	18
Additional Paid-In Capital	3.72	3.72	3.72	3.72	3.72
Retained Earnings	51.58	42.83	39.6	34.9	29.89
Comprehensive Income & Other	13.82	6.04	6.52	7.65	14.87
Total Common Equity	87.11	70.6	67.84	64.27	66.47
Minority Interest	1.08	1.01	1.04	0.96	2.1
Shareholders' Equity	88.2	71.61	68.88	65.23	68.57
Total Liabilities & Equity	114.59	89.15	86.32	83.72	86.89
Total Debt	1.32	1.51	2.47	2.18	2.63
Net Cash (Debt)	10.9	10.23	4.17	5.6	2.86
Net Cash Growth	6.53%	145.52%	-25.64%	95.69%	-
Net Cash Per Share	0.30	0.28	0.12	0.16	0.08
Filing Date Shares Outstanding	36	36	36	36	36
Total Common Shares Outstanding	36	36	36	36	36
Working Capital	46.49	39.53	38.28	39.2	42.16
Book Value Per Share	2.42	1.96	1.88	1.79	1.85
Tangible Book Value	84.44	68.8	66.29	62.75	63.43
Tangible Book Value Per Share	2.35	1.91	1.84	1.74	1.76
Land	10.43	9.49	10.63	9.24	8.31
Buildings	16.73	15.42	15.64	15.73	16.34
Machinery	35.71	30.8	29.47	28.78	31.82
Construction In Progress	0.01	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.